X0306 4 2020-02-03 false 0001271214 Intersect ENT, Inc. XENT 0001620705 West Thomas A. C/O INTERSECT ENT, INC. 1555 ADAMS DRIVE MENLO PARK CA 94025 true true false false President and CEO Common Stock 2020-02-03 4 A false 39700.00 0.00 A 178155.00 D Common Stock 2020-02-03 4 A false 39700.00 0.00 A 217855.00 D Stock Options (Right to buy) 26.18 2020-02-03 4 A false 78700.00 0.00 A 2030-02-03 Common Stock 78700.00 78700.00 D Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units shall vest on the third anniversary from the date of grant provided that certain 30-day trailing average stock price (the "Average Closing Price") targets are achieved at any time during the three year period following the date of grant. 33 1/3%, 66 2/3% or 100% of the shares will vest if the Average Closing Price equals or exceeds specific stock price targets. Restricted stock units, of which 39,700 are performance based. Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units vest in three equal annual installments commencing one year after the grant date. The vesting commencement date of the option is February 3, 2020. 1/8th of the shares subject to the option shall vest on August 3, 2020 and 1/48th of the shares subject to the option shall vest monthly thereafter over 42 months. /s/ David A. Lehman, Attorney-in-Fact for Thomas A West 2020-02-05